250
Participants
Start Date
September 1, 2017
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2027
Bortezomib
Patients randomised to the HR-B arm receive induction, consolidation with the modified ALL R3 protocol. In this arm, patients are randomized to receive Bortezomib together with the ALL R3 protocol during induction. Administration of Bortezomib: 1.3 mg/m2 as intravenous bolus or subcutaneously (SC, at the discretion of the treating physician) on days 1 and 4 of weeks 1 and 3.
RECRUITING
Hòpital Universitaire des Enfants Reine Fabiola, Brussels
RECRUITING
St. Anna Kinderkrebsforschung, CCRI, Vienna
NOT_YET_RECRUITING
Copenhagen University Hospital (Rigshospitalet), Copenhagen
RECRUITING
Australian & New Zealand Childhood Hematology & Oncology Group, Clayton
NOT_YET_RECRUITING
University Hospital Stockholm, Stockholm
RECRUITING
Dpt. SCT and Hematology/Oncology University Wroclaw, Wroclaw
RECRUITING
Tel Aviv Sourasky Medical Centre, Tel Aviv
RECRUITING
University Hospital Motol, Prague
RECRUITING
CHU Nice, Nice
RECRUITING
Prinses Máxima Centrum, Lundlaan, Utrecht
NOT_YET_RECRUITING
Instituto Português de Oncologia de Lisboa, Lisbon
RECRUITING
Turku University Central Hospital, Turku
RECRUITING
Ospedale Pediatrico Bambino Gesù, Roma
NOT_YET_RECRUITING
Oslo University Hospital, Oslo
NOT_YET_RECRUITING
Royal Manchester Children's Hospital, Manchester
Australian & New Zealand Children's Haematology/Oncology Group
OTHER
St. Anna Kinderkrebsforschung, CCRI (co-sponsor, Austria)
UNKNOWN
European Organisation for Research and Treatment of Cancer - EORTC
NETWORK
University Hospital Motol (Co-Sponsor Czech Republic)
UNKNOWN
Copenhagen University Hospital, Rigshospitalet (co-sponsor, Denmark)
UNKNOWN
Turku University Central Hospital (co-sponsor, Finland)
UNKNOWN
Centre Hospitalier Universitaire de Nice
OTHER
Our Lady's Chilrden's Hospital (Co-Sponsor Ireland)
UNKNOWN
Tel Aviv Sourasky Medical Centre (Co-Sponsor Israel)
UNKNOWN
Ospedale Pediatrico Bambino (co-sponsor, Italy)
UNKNOWN
Prinses Máxima Centrum (Co-Sponsor Netherlands)
UNKNOWN
Oslo University Hospital (co-sponsor, Norway)
UNKNOWN
Medical University of Wroclaw (Co-Sponsor Poland)
UNKNOWN
Instituto Português de Oncologia de Lisboa (co-sponsor, Portugal)
UNKNOWN
Karolinska University Hospital Stockholm (co-sponsor, Sweden)
UNKNOWN
Spanish Society of Pediatric Hematology and Oncology (SEHOP) (Co-Sponsor Spain)
UNKNOWN
University Children's Hospital, Zurich
OTHER
Central Manchester University Hospitals NHS Foundation Trust (co-sponsor, UK)
UNKNOWN
Charite University, Berlin, Germany
OTHER